AUS
NZ
UK
CA
USA
IND
Healthcare
CleanSpace Holdings and the All Ordinaries Amid a Shifting Commercial Equipment Landscape
November 17, 2025 05:09 PM AEDT| By SamCleanSpace Holdings’ recent operational update highlights themes surrounding manufacturing alignment, procurement cycles, and product distribution across safety-focused industries.
Recce Pharmaceuticals and the Evolving ASX 200 Landscape
November 17, 2025 01:16 PM AEDT| By SamRecce Pharmaceuticals reflects on the scientific legacy behind its technology platform, reinforcing its ongoing commitment to innovative anti-infective research within a dynamic Australian market landscape.
Bioxyne expands therapeutic footprint with new UK facility ASX 200
November 17, 2025 01:09 PM AEDT| By SamBioxyne expands its international therapeutic footprint through a new UK facility and evolving supply of regulated medicines, strengthening its presence across global alternative-treatment markets.
Race Oncology expands clinical programs with sector updates
November 17, 2025 01:06 PM AEDT| By SamRace Oncology expands programs in AML and lung cancer while progressing ongoing cardioprotection research and broader development planning.
Pro Medicus Moves Higher as Sector Interest Builds Across the ASX 200
November 17, 2025 11:53 AM AEDT| By SamPro Medicus gained early attention following a major enterprise contract, reinforcing confidence in cloud-based imaging solutions as broader ASX sectors observe steady engagement across technology, healthcare, and diversified market categories.
Trajan Group Holdings Faces Market Pressure Amid Shifting Sentiment ASX 200
November 17, 2025 10:54 AM AEDT| By SamTrajan Group Holdings navigates shifting market sentiment as observers reassess revenue momentum, sector context, and broader index movements influencing trade across the Australian market.
Pro Medicus Overview (ASX:PME) Across ASX 200 Healthcare Technology Landscape
November 14, 2025 06:47 PM AEDT| By SamExtensive overview of Pro Medicus, covering its enterprise imaging systems, workflow-technology operations, sector environment and representation across key ASX indices.
Australian Clinical Labs Overview (ASX:ACL) in the All Ordinaries Healthcare Landscape
November 14, 2025 06:35 PM AEDT| By SamAustralian Clinical Labs’ diagnostic operations, laboratory infrastructure, and sector activity, highlighting its position within the All Ordinaries index.
ASX 200 Update: Telix Pharmaceuticals (ASX:TLX) Drops as US Class Actions Mount
November 14, 2025 01:56 PM AEDT| By SamTelix Pharmaceuticals shares weakened after multiple US class actions alleged overstated progress on prostate cancer candidates and supply chain strength. The filings added pressure to a market already trading with softer sentiment.
ASX 200 Spotlight: Mach7 Technologies Faces Pressure as Revenue Trends Lag Sector Strength
November 14, 2025 12:15 PM AEDT| By SamMach7 Technologies’ valuation remains subdued as investors track revenue momentum against a rapidly expanding healthcare services sector. Market caution persists until growth consistency strengthens.
Sonic Healthcare’s Diagnostic Position Across the ASX 100 Healthcare Sector
November 13, 2025 08:54 PM AEDT| By SamSonic Healthcare’s diagnostic operations, laboratory capability, scientific programs and governance activity are highlighted through detailed sector-related information.
Arovella Therapeutics Lists New Securities on the ASX
November 13, 2025 11:32 AM AEDT| By SamArovella Therapeutics (ASX:ALA) has listed new securities on the ASX, reinforcing its biotechnology focus and supporting its ongoing therapeutic development goals within the evolving Australian market landscape.
Telix Pharmaceuticals Expands Healthcare Reach in ASX 200 Amid Biotech Advances
November 12, 2025 05:58 PM AEDT| By SamTelix Pharmaceuticals Limited (ASX:TLX) remains a vital player in the Australian biotechnology and healthcare industry, representing innovation within the ASX 200 through radiopharmaceutical advancements.
Telix Pharmaceuticals in ASX 200 Radiopharmaceutical Leadership in Australian Biotech
November 12, 2025 04:00 PM AEDT| By SamTelix Pharmaceuticals Limited, a key member of the ASX 200, develops diagnostic and therapeutic radiopharmaceuticals, supported by international manufacturing and research operations.
ASX 200 Healthcare Innovator Nanosonics Limited (ASX:NAN) Enhances Infection Prevention Technology
November 10, 2025 04:27 PM AEDT| By SamNanosonics Limited (ASX:NAN) develops medical disinfection technologies that enhance infection control standards globally through innovation, automation, and sustainable healthcare practices.
Artrya Limited (ASX:AYA) Strengthens Role within ASX 100 Health-Tech and AI Diagnostics Sector
November 10, 2025 04:20 PM AEDT| By SamArtrya Limited (ASX:AYA) focuses on artificial intelligence applications in cardiovascular diagnostics, advancing healthcare imaging through innovation, collaboration, and sustainable development in Australia’s medtech sector.
CSL and Pro Medicus: Healthcare Momentum in ASX 200
November 10, 2025 12:50 PM AEDT| By SamCSL and Pro Medicus represent the evolving face of Australian healthcare innovation within the ASX 200, combining medical advancement and digital transformation to strengthen market confidence.
Artrya (ASX:AYA) Evaluation Amid Earnings Outlook
November 10, 2025 12:17 PM AEDT| By SamArtrya (ASX:AYA) remains in focus ahead of its earnings call, as market observers assess its valuation, innovation trajectory, and alignment with broader ASX healthcare trends.
Ramsay Health Care Faces Operational Pressure Amid ASX 50 Landscape
November 07, 2025 11:08 PM AEDT| By SamRamsay Health Care Ltd (ASX:RHC) faces operational headwinds in the ASX 50 landscape, as dividend intensity and low ROE weigh on reinvestment capacity and profitability metrics.
Investors Reassess Outlook for Oneview Healthcare (ASX:ONE) Amid Industry Challenges
November 07, 2025 11:43 AM AEDT| By SamInvestor sentiment toward Oneview Healthcare (ASX:ONE) remains cautious as growth expectations lag peers within Australia’s evolving digital healthcare market.
Advertise your brand on Kalkine Media